succinylacetone has been researched along with Acute Disease in 2 studies
succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Results of NTBC therapy used in three infants with type I tyrosinemia who presented with acute liver failure are reported." | 3.70 | [Favorable outcome of treatment with NTBC of acute liver insufficiency disclosing hereditary tyrosinemia type I]. ( Barkaoui, E; Bernard, O; Debray, D; Habès, D; Ogier, H, 1999) |
| "Hereditary tyrosinemia type 1 (HT1) is a severe autosomal recessive metabolic disease associated with point mutations in the human fumarylacetoacetate hydrolase (FAH) gene that disrupt tyrosine catabolism." | 1.31 | Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1. ( Aponte, JL; Carpenter, DA; Culiat, CT; Dhar, MS; Hauser, LJ; Johnson, DK; Rinchik, EM; Sega, GA; Withrow, CM, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barkaoui, E | 1 |
| Debray, D | 1 |
| Habès, D | 1 |
| Ogier, H | 1 |
| Bernard, O | 1 |
| Aponte, JL | 1 |
| Sega, GA | 1 |
| Hauser, LJ | 1 |
| Dhar, MS | 1 |
| Withrow, CM | 1 |
| Carpenter, DA | 1 |
| Rinchik, EM | 1 |
| Culiat, CT | 1 |
| Johnson, DK | 1 |
2 other studies available for succinylacetone and Acute Disease
| Article | Year |
|---|---|
[Favorable outcome of treatment with NTBC of acute liver insufficiency disclosing hereditary tyrosinemia type I].
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Acute Disease; Amino Acid Metabolism, Inborn Errors; Aminolevul | 1999 |
Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1.
Topics: Acute Disease; Alleles; Amino Acid Substitution; Animals; Animals, Newborn; Base Sequence; Biomarker | 2001 |